In a 71-year-old, 50-kg female with anxiety, depression, and hypertension who is found unconscious with hypotension, bradycardia, and a widened QRS interval after an overdose of metoprolol succinate and amlodipine, which initial therapy should be given in addition to an intravenous norepinephrine infusion?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Calcium Gluconate 3 g IV Over 10 Minutes and Sodium Bicarbonate 50 mEq as an IV Bolus

For this patient with combined beta-blocker and calcium channel blocker overdose presenting with severe hypotension, bradycardia, and widened QRS interval, you should administer calcium gluconate 3 g IV over 10 minutes and sodium bicarbonate 50 mEq as an IV bolus in addition to norepinephrine infusion.

Rationale for This Recommendation

The Critical Issue: Combined Toxicity with Sodium Channel Blockade

This patient has ingested approximately one week's supply of both metoprolol succinate (beta-blocker) and amlodipine (dihydropyridine calcium channel blocker). The widened QRS interval is the key finding that drives therapy selection—this indicates sodium channel blockade, which can occur with certain beta-blockers like propranolol or from co-ingested medications. The fluoxetine overdose is likely contributing to this QRS widening through its sodium channel blocking effects.

Why Calcium Gluconate is Essential

  • For CCB toxicity: The 2023 AHA guidelines recommend calcium as first-line therapy for calcium channel blocker poisoning 1
  • For combined toxicity: The 2017 expert consensus specifically recommends IV calcium as first-line therapy for CCB poisoning (1D recommendation) 2
  • Recent case reports demonstrate successful management of amlodipine-atenolol overdose with IV calcium infusion as a core component 3, 4
  • Calcium directly counteracts the L-type calcium channel blockade caused by amlodipine

Why Sodium Bicarbonate is Critical

  • The widened QRS interval mandates sodium bicarbonate administration—this is standard toxicology practice for sodium channel blockade
  • Sodium bicarbonate works by increasing extracellular sodium concentration and raising serum pH, which helps overcome sodium channel blockade
  • The target is to narrow the QRS interval and prevent progression to ventricular dysrhythmias
  • This addresses the likely fluoxetine contribution to toxicity

Why NOT Lipid Emulsion in This Scenario

The 2023 AHA guidelines explicitly state that "Intravenous lipid emulsion therapy is not likely to be beneficial for life-threatening β-blocker poisoning" (Class 3: No Benefit, Level C-LD) 1. While lipid emulsion has been used in some case reports of combined toxicity 4, it should be reserved for refractory cases after first-line therapies have failed, not as initial therapy.

Why NOT Insulin at This Stage

  • High-dose insulin therapy is recommended for hypotension refractory to or in conjunction with vasopressor therapy 1
  • The patient is already receiving norepinephrine
  • Insulin should be added if hypotension persists despite calcium, bicarbonate, and vasopressors
  • Regular insulin 100 units as an IV bolus is an inappropriate dose—high-dose insulin therapy typically starts at 1 unit/kg bolus followed by 0.5-1 unit/kg/hour infusion with dextrose supplementation to maintain euglycemia

Algorithmic Approach to This Patient

Immediate Priorities (First 30 Minutes):

  1. Calcium gluconate 3 g IV over 10 minutes (addresses amlodipine toxicity)
  2. Sodium bicarbonate 50 mEq IV bolus (addresses QRS widening from sodium channel blockade)
  3. Continue norepinephrine infusion (already established for vasopressor support)
  4. Monitor QRS interval on continuous ECG—repeat bicarbonate boluses until QRS narrows
  5. Check serum glucose, potassium, calcium levels

If Hypotension Persists After Initial Therapy:

  1. Add high-dose insulin euglycemia therapy: 1 unit/kg IV bolus, then 0.5-1 unit/kg/hour infusion 1, 2
  2. Administer dextrose 25-50 g IV bolus, then start dextrose infusion to maintain glucose 100-200 mg/dL
  3. Consider glucagon: 5-10 mg IV bolus, then 2-10 mg/hour infusion for beta-blocker effects 1
  4. Escalate vasopressor support as needed

If Refractory Shock Develops:

  1. Increase insulin infusion incrementally (up to 10 units/kg/hour has been used)
  2. Consider lipid emulsion therapy at this stage: 1.5 mL/kg (75 mL for 50 kg patient) IV bolus over 1 minute, then 0.25 mL/kg/min infusion 2
  3. Prepare for VA-ECMO if available and shock remains refractory 1, 2

Critical Pitfalls to Avoid

  • Do not give insulin 100 units as a bolus without dextrose—this will cause severe, life-threatening hypoglycemia
  • Do not use lipid emulsion as first-line therapy for beta-blocker toxicity—guidelines recommend against this 1
  • Do not forget to repeat sodium bicarbonate if QRS remains widened—may need multiple boluses
  • Monitor for hypocalcemia, hypokalemia, and hypoglycemia aggressively—these are common complications
  • The patient will likely require prolonged monitoring (48-72 hours minimum) given the sustained-release formulation of metoprolol succinate and the long half-life of amlodipine 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.